Everand Logo

Welcome to Everand!

  • STAT

    STAT+: Pharmalittle: We’re reading about the Purdue bankruptcy ruling, a Merck rejection, and more

    In today's Pharmalittle roundup, we're reading about the Purdue bankruptcy ruling, a Merck rejection, and more.
    by Ed Silverman Jun 28, 2024 1 minute
    Source: Alex Hogan/STAT

    And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is fairly modest. We, , , , and . And what about you? This is a grand time to enjoy the great outdoors. Beaches and lakes are beckoning. City streets want to be strolled. And woods are inviting the adventurous for long mysterious walks. Take your pick. Or you could simply hide indoors and binge-watch something on the telly. Well, whatever you do, have a grand time. But be safe. Enjoy, and see you soon …

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About EMA Plans For GLP-1 Shortages, Walgreens Store Closings, And More
    The European Medicines Agency and member countries announced several steps to address shortages of GLP-1 drugs.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About Abortion Pill Access, Employer Coverage Of GLP-1 Drugs And More
    Updates from the Pharmalittle newsletter campus: —FDA advised drugmakers to update Covid vaccines to target the KP.2 strain —Leadership from Done startup were arrested and charged with fraud —U.S. authorities…
    STAT1 min read
    STAT+: How A Tweet About A Gene Discovered Long Ago Led To A $190 Million Startup And, Maybe, Hope For Heart Disease
    A 10-person startup called Marea has raised $190 million to help develop a drug to lower a type of cholesterol and a new way of attacking cardiovascular disease.

    Related Books & Audiobooks